{
    "SLC22A7": {
        "expression": [
            {
                "Organ": "Brain",
                "Source": "Nishimura",
                "Relative Expression": 0.000555
            },
            {
                "Organ": "Kidney*",
                "Source": "Nishimura",
                "Relative Expression": 0.471
            },
            {
                "Organ": "Liver*",
                "Source": "Nishimura",
                "Relative Expression": 0.818
            },
            {
                "Organ": "Placenta",
                "Source": "Nishimura",
                "Relative Expression": 5.03e-05
            },
            {
                "Organ": "Small Intestine",
                "Source": "Nishimura",
                "Relative Expression": 0.000686
            },
            {
                "Organ": "Liver*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 128.423
            },
            {
                "Organ": "Kidney*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 14.003
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "Bumetanide",
                "IC50 (μM)": 77.5,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Cefamandole",
                "IC50 (μM)": 1570.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cefoperazone",
                "IC50 (μM)": 1330.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cefotaxime",
                "IC50 (μM)": 4680.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cephaloridine",
                "IC50 (μM)": 4480.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cephalothin",
                "IC50 (μM)": 1410.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Chlorothiazide",
                "IC50 (μM)": 2205.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Cyclic GMP",
                "IC50 (μM)": null,
                "Ki (μM)": 93.0,
                "Substrate used": "2'-deoxyguanosine",
                "Cell System": "HEK-OAT2",
                "Reference": "Cropp, 2008"
            },
            {
                "Inhibitor": "Cyclothiazide",
                "IC50 (μM)": 39.2,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Diclofenac",
                "IC50 (μM)": 14.3,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Ethacrynic acid",
                "IC50 (μM)": 121.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Furosemide",
                "IC50 (μM)": 603.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Hydrochlorothiazide",
                "IC50 (μM)": 1023.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Ibuprofen",
                "IC50 (μM)": 692.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Indomethacin",
                "IC50 (μM)": 64.1,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Ketoprofen",
                "IC50 (μM)": 400.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Mefenamic acid",
                "IC50 (μM)": 21.7,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Naproxen",
                "IC50 (μM)": 486.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Phenacetin",
                "IC50 (μM)": 1878.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Piroxicam",
                "IC50 (μM)": 70.3,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Probenecid",
                "IC50 (μM)": null,
                "Ki (μM)": 766.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Enomoto, 2002"
            },
            {
                "Inhibitor": "Sulindac",
                "IC50 (μM)": 440.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Trichloromethiazide",
                "IC50 (μM)": 1120.0,
                "Ki (μM)": null,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT2",
                "Reference": "Hasannejad, 2004"
            }
        ],
        "substrates": [
            {
                "Substrate": "2'-deoxyguanosine",
                "Km (μM)": 128.0,
                "Cell System": "HEK-OAT2",
                "Reference": "Cropp, 2008"
            },
            {
                "Substrate": "5-fluorouracil",
                "Km (μM)": 0.0538,
                "Cell System": "OAT2-expressing oocytes",
                "Reference": "Kobayashi, 2005"
            },
            {
                "Substrate": "Bumetanide",
                "Km (μM)": 7.52,
                "Cell System": "OAT2-expressing oocytes",
                "Reference": "Kobayashi, 2005"
            },
            {
                "Substrate": "Cyclic GMP",
                "Km (μM)": 88.0,
                "Cell System": "HEK-OAT2",
                "Reference": "Cropp, 2008"
            },
            {
                "Substrate": "Erythromycin",
                "Km (μM)": 18.5,
                "Cell System": "OAT2-expressing oocytes",
                "Reference": "Kobayashi, 2005"
            },
            {
                "Substrate": "Paclitaxel",
                "Km (μM)": 0.1428,
                "Cell System": "OAT2-expressing oocytes",
                "Reference": "Kobayashi, 2005"
            },
            {
                "Substrate": "Prostaglandin E2",
                "Km (μM)": 0.713,
                "Cell System": "S2-OAT2",
                "Reference": "Kimura, 2002"
            },
            {
                "Substrate": "Prostaglandin F2alpha",
                "Km (μM)": 0.425,
                "Cell System": "S2-OAT2",
                "Reference": "Enomoto, 2002"
            },
            {
                "Substrate": "Tetracycline",
                "Km (μM)": 439.9,
                "Cell System": "S2-OAT2",
                "Reference": "Babu, 2002"
            },
            {
                "Substrate": "Theophylline",
                "Km (μM)": 12.6,
                "Cell System": "OAT2-expressing oocytes",
                "Reference": "Kobayashi, 2005"
            },
            {
                "Substrate": "Zidovudine",
                "Km (μM)": 26.8,
                "Cell System": "S2-OAT2",
                "Reference": "Takeda, 2002"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "OATs/OCTs",
                "Interacting Drug": "Cotrimoxazole (trimethoprim/sulfamethoxazole)",
                "Affected Drug": "Apricitabine",
                "AUC": "1.7",
                "Cmax": "1.3",
                "CLR": "0.6",
                "CL/F": "0.6",
                "t1/2": "1.4",
                "Effect on PD": "ND",
                "Reference": "Shiveley, 2008",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "OATs/OCTs",
                "Interacting Drug": "Cotrimoxazole (trimethoprim/sulfamethoxazole)",
                "Affected Drug": "Zidovudine",
                "AUC": "NS",
                "Cmax": "ND",
                "CLR": "0.4",
                "CL/F": "NS",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Chatton, 1992",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Furosemide",
                "Affected Drug": "Lomefloxacin",
                "AUC": "1.1",
                "Cmax": "NS",
                "CLR": "0.7",
                "CL/F": "0.9",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Sudoh, 1994",
                "More Details": "DDI 3"
            },
            {
                "DDI": "4",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Acyclovir",
                "AUC": "1.4",
                "Cmax": "ND",
                "CLR": "0.7",
                "CL/F": "NS",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Laskin, 1982",
                "More Details": "DDI 4"
            },
            {
                "DDI": "5",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cefaclor",
                "AUC": "2.1",
                "Cmax": "1.5",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "1.6",
                "Effect on PD": "ND",
                "Reference": "Welling, 1979",
                "More Details": "DDI 5"
            },
            {
                "DDI": "6",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cefonicid",
                "AUC": "2.1",
                "Cmax": "1.2",
                "CLR": "0.3",
                "CL/F": "ND",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Pitkin, 1981",
                "More Details": "DDI 6"
            },
            {
                "DDI": "7",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cefoxitin",
                "AUC": "2.4",
                "Cmax": "ND",
                "CLR": "0.4",
                "CL/F": "ND",
                "t1/2": "2.0",
                "Effect on PD": "ND",
                "Reference": "Vlasses, 1980",
                "More Details": "DDI 7"
            },
            {
                "DDI": "8",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Ceftriaxone",
                "AUC": "0.7",
                "Cmax": "ND",
                "CLR": "ND",
                "CL/F": "1.3",
                "t1/2": "0.8",
                "Effect on PD": "ND",
                "Reference": "Stoeckel, 1988",
                "More Details": "DDI 8"
            },
            {
                "DDI": "9",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cephradine",
                "AUC": "2.4",
                "Cmax": "1.9",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Welling, 1979",
                "More Details": "DDI 9"
            },
            {
                "DDI": "10",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cidofovir",
                "AUC": "ND",
                "Cmax": "ND",
                "CLR": "0.5",
                "CL/F": "0.6",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Cundy, 1995",
                "More Details": "DDI 10"
            },
            {
                "DDI": "11",
                "Implicated Transporter": "OATs/MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Ciprofloxacin",
                "AUC": "1.7",
                "Cmax": "NS",
                "CLR": "0.4",
                "CL/F": "0.6",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Jaehde, 1995",
                "More Details": "DDI 11"
            },
            {
                "DDI": "12",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Dicloxacillin",
                "AUC": "1.9",
                "Cmax": "1.8",
                "CLR": "0.3",
                "CL/F": "0.5",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Beringer, 2008",
                "More Details": "DDI 12"
            },
            {
                "DDI": "13",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Famotidine",
                "AUC": "1.8",
                "Cmax": "1.5",
                "CLR": "0.4",
                "CL/F": "0.1",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Inotsume, 1990",
                "More Details": "DDI 13"
            },
            {
                "DDI": "14",
                "Implicated Transporter": "OATs/MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Furosemide",
                "AUC": "2.7",
                "Cmax": "1.5",
                "CLR": "0.3",
                "CL/F": "0.4",
                "t1/2": "1.7",
                "Effect on PD": "ND",
                "Reference": "Vree, 1995",
                "More Details": "DDI 14"
            }
        ]
    }
}